Full title: Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (CabOSTar)
Phase: II
Age: 5 – 30 years old
Locations:
- Cambridge – Cambridge University Hospital
- London – University College London Hospital
- Manchester – Christie Hospital
Brief summary:
CabOSTar is a phase II is an international clinical trial examining cabozantinib and best supportive care versus the best supportive care alone in children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
